Empresa MYnd Analytics Inc Nasdaq
Acciones
US62857N2027
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 21 | 100,0 % | 18 | 100,0 % | -10,77 % |
Ventas por región
USD en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 21 | 100,0 % | 18 | 100,0 % | -10,77 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
George Sekulich
PSD | President | 59 | 01/05/19 |
Willis Lee
CHM | Chairman | 64 | 17/07/19 |
Yasushi Nagasaki
DFI | Director of Finance/CFO | 57 | 01/05/11 |
Mark Diamond
CIO | Chief Investment Officer | - | - |
Charles Stark
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/01/13 |
Lan T. Tran
ADM | Chief Administrative Officer | 48 | 17/07/19 |
Dale E. Short
SEC | Corporate Secretary | - | 01/09/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Wei Peu Zen
BRD | Director/Board Member | 71 | 17/07/19 |
Willis Lee
CHM | Chairman | 64 | 17/07/19 |
Ian Zwicker
BRD | Director/Board Member | 77 | 17/07/19 |
George Sekulich
PSD | President | 59 | 01/05/19 |
Seah LIm
BRD | Director/Board Member | 66 | 04/10/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 53 637 554 | 25 870 168 ( 48,23 %) | 0 | 48,23 % |
Información de la empresa
Emmaus Life Sciences, Inc.
21250 Hawthorne Boulevard Suite 800
90503, Torrance
+
http://www.emmausmedical.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+51,85 % | 57,87 mil M | |
+41,42 % | 40,25 mil M | |
-5,25 % | 39,94 mil M | |
-5,16 % | 28,54 mil M | |
+12,79 % | 26,4 mil M | |
-20,18 % | 19,33 mil M | |
+30,88 % | 12,4 mil M | |
+0,61 % | 12,23 mil M | |
+25,06 % | 12,2 mil M |